Artículos con órdenes de acceso público - Jo VandesompeleMás información
TotalFWONIHEuropean CommissionGobierno de EspañaNHMRCSFIDFGNSFCBMBFDOECancer Research UKMRCAIRC Foundation for Cancer Research in ItalySNSFFWFFNRSHelmholtzDFFVillum FoundationBBSRCWellcomeZonMwANRBELSPOFAPESPHHMICIHROTKANWOKnut and Alice Wallenberg FoundationBHFEPSRCAction on Hearing Loss, UKSTFCARRSKNAWKWFUK Research & InnovationJDRFBrain Tumour Charity, UKMelanoma Research AllianceCZI
No disponibles en ningún lugar: 18
Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study
P Mestdagh, N Hartmann, L Baeriswyl, D Andreasen, N Bernard, C Chen, ...
Nature methods 11 (8), 809-815, 2014
Órdenes: Research Foundation (Flanders)
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
JJ Molenaar, R Domingo-Fernández, ME Ebus, S Lindner, J Koster, ...
Nature genetics 44 (11), 1199-1206, 2012
Órdenes: US National Institutes of Health, Science Foundation Ireland
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab
B Jacobs, W De Roock, H Piessevaux, R Van Oirbeek, B Biesmans, ...
Journal of clinical oncology 27 (30), 5068-5074, 2009
Órdenes: Research Foundation (Flanders)
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
S De Brouwer, K De Preter, C Kumps, P Zabrocki, M Porcu, ...
Clinical cancer research 16 (17), 4353-4362, 2010
Órdenes: Research Foundation (Flanders)
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
LC Heukamp, T Thor, A Schramm, K De Preter, C Kumps, B De Wilde, ...
Science translational medicine 4 (141), 141ra91-141ra91, 2012
Órdenes: Research Foundation (Flanders), German Research Foundation
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
P Mestdagh, E Fredlund, F Pattyn, JH Schulte, D Muth, J Vermeulen, ...
Oncogene 29 (9), 1394-1404, 2010
Órdenes: Research Foundation (Flanders)
MiR‐137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A
K Althoff, A Beckers, A Odersky, P Mestdagh, J Köster, IM Bray, K Bryan, ...
International journal of cancer 133 (5), 1064-1073, 2013
Órdenes: US National Institutes of Health, Science Foundation Ireland
Revised risk estimation and treatment stratification of low-and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
A Oberthuer, D Juraeva, B Hero, R Volland, C Sterz, R Schmidt, A Faldum, ...
Clinical Cancer Research 21 (8), 1904-1915, 2015
Órdenes: Gobierno de España
Comparison of miRNA profiles of microdissected Hodgkin/Reed‐Sternberg cells and Hodgkin cell lines versus CD77+ B‐cells reveals a distinct subset of …
P Van Vlierberghe, AN De Weer, P Mestdagh, T Feys, K De Preter, ...
British journal of haematology 147 (5), 686-690, 2009
Órdenes: Research Foundation (Flanders)
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer
T Van Maerken, A Rihani, A Van Goethem, A De Paepe, F Speleman, ...
Cancer letters 344 (2), 157-165, 2014
Órdenes: Research Foundation (Flanders)
Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia
A Wallaert, K Durinck, W Van Loocke, I Van de Walle, F Matthijssens, ...
Leukemia 30 (9), 1927-1930, 2016
Órdenes: Research Foundation (Flanders)
Neuroblastoma genetics and phenotype: a tale of heterogeneity
F Speleman, K De Preter, J Vandesompele
Seminars in cancer biology 21 (4), 238-244, 2011
Órdenes: Research Foundation (Flanders)
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma
A Rihani, T Van Maerken, B De Wilde, F Zeka, G Laureys, K Norga, ...
Pediatric blood & cancer 61 (10), 1867-1870, 2014
Órdenes: Research Foundation (Flanders), Gobierno de España
Corrigendum: Differential expression of lncRNAs during the HIV replication cycle: an underestimated layer in the HIV-host interplay
W Trypsteen, P Mohammadi, C Van Hecke, P Mestdagh, S Lefever, ...
Scientific Reports 7, 2017
Órdenes: Swiss National Science Foundation, Research Foundation (Flanders)
Recombinant extracellular vesicles: biological reference material to standardize extracellular vesicle research
E Geeurickx, E Heyrman, J Van Deun, L Lippens, J Tulkens, B Dhondt, ...
Journal of Extracellular Vesicles 7, 268-268, 2018
Órdenes: Research Foundation (Flanders)
Low-cost dedicated mini-arrays for high-throughput analysis of DNA copy-number alterations in neuroblastoma
K De Preter, B Menten, S De Brouwer, C Kumps, E Michels, N Van Roy, ...
Cancer letters 269 (1), 111-116, 2008
Órdenes: Research Foundation (Flanders)
Circulating microRNA biomarkers for metastatic neuroblastoma
F Zeka, A Van Goethem, T Lammens, A Decock, H Helsmoortel, ...
Advances in Neuroblastoma Research 2018 (ANR 2018), 2018
Órdenes: Gobierno de España
The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition
L Gamble, S Purgato, S Di Giacomo, A Russell, P Pigini, E Valli, L Ashton, ...
Advances in Neuroblastoma Research 2018 (ANR 2018), 2018
Órdenes: Gobierno de España
Disponibles en algún lugar: 186
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
SA Bustin, V Benes, JA Garson, J Hellemans, J Huggett, M Kubista, ...
Clinical chemistry 55 (4), 611-622, 2009
Órdenes: Research Foundation (Flanders), Cancer Research UK
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
L Ma, J Young, H Prabhala, E Pan, P Mestdagh, D Muth, ...
Nature cell biology 12 (3), 247-256, 2010
Órdenes: US National Institutes of Health, Howard Hughes Medical Institute
La información de publicación y financiación se determina de forma automática mediante un programa informático